Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

25.65 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
99 100 Next >
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
These healthcare stocks offer completely different approaches to long-term investment gains. 
Via The Motley Fool
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Pfizer seeks to expands its reach with 'Pfizer for All,' offering direct-to-consumer medical services, including COVID treatments & telehealth. 
Via Benzinga
Exposures COVID-19
Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector
Pfizer and AstraZeneca invest over $1 billion in France's healthcare sector, bolstering R&D capabilities and job creation. 
Via Benzinga
How Viking Therapeutics Stock Could 30x
This mid-cap biopharma may one day be a titan of the industry. 
Via The Motley Fool
2 Beaten-Down Stocks to Buy and Hold for 10 Years
They offer plenty of upside and solid dividend growth. 
Via The Motley Fool
Spotlight on Pfizer: Analyzing the Surge in Options Activity
Via Benzinga
Generis Welcomes Max Kelleher as New Chief Executive Officer
LONDON - May 14, 2024 - PRLog -- Generis, creator of the cloud data, content, and business process management platform CARA™, today announced that Max Kelleher will be stepping into the role of Chief... 
Via PRLog
Is This a Setback for Moderna?
Moderna's shares slipped after the company announced the delay. 
Via The Motley Fool
3 Stocks That Suddenly Drew in Options Traders
Three discounted stocks caught the attention of call option buyers last week, and they have Wall Street analysts to back them through double-digit upside. 
Via MarketBeat
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock
Pfizer stock currently has a 5.9% dividend yield, making it an attractive target for income investors. 
Via The Motley Fool
'Seems Low:' Elon Musk Questions Pfizer's $0 Tax Bill, But Did Tesla Pony Up To Uncle Sam?
In December 2021, Musk paid a record-breaking $11 billion in federal income taxes, resulting from selling Tesla stock to finance his purchase of Twitter. 
Via Benzinga
Earn $1000 Every Month From These 3 Stocks
All 3 companies pay growing dividends. 
Via The Motley Fool
Top Stock Reports For Amazon.com, Visa & Pfizer
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc., Visa Inc.. and Pfizer Inc. 
Via Talk Markets
The 10 Worst Performing S&P 500 Stocks in 2023 - Are They Good Investments Now?
A look at the 10 worst-performing S&P 500 stocks in 2023. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Stocks Surge On Healthy Earnings Season, Rising Jobless Claims: This Week In The Markets
Week in markets: quiet week, Q1 earnings positive, S&P 500 and Dow Jones up, utilities sector stands out, job market and inflation concerns, interest rate cuts expected. Buffett reduces Apple stake,... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
FDA Delays 'Important' Moderna Vaccine Review: William Blair Says 2025 Growth, '2026 Breakeven Story' Depends On It
FDA update: Moderna's BLA for mRNA-1345, RSV vaccine, may face delay past May 12 deadline. But no safety concerns reported. 
Via Benzinga
Exposures Product Safety
Moderna Dives Back Into Buy Zone After FDA Delays Its RSV Vaccine
The FDA hasn't said there are any vaccine effectiveness, safety or quality issues that would prevent approval, Moderna says. 
Via Investor's Business Daily
Exposures Product Safety
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields
Via Benzinga
7 F-Rated Stock Picks to Avoid Like the Plague in May
Consumer stocks, electric vehicle companies and meme stocks top the list of F-rated stock picks to avoid this month. 
Via InvestorPlace
Topics Electric Vehicles
Exposures Electric Vehicles
3 Biotech Stocks to Sell in May Before They Crash & Burn
Discover essential insights on biotech stocks to sell in May to navigate market volatility and safeguard your investment portfolio. 
Via InvestorPlace
The 3 Most Undervalued Healthcare Stocks to Buy in May 2024
These are the undervalued healthcare stocks to buy as they represent companies with steady growth visibility. 
Via InvestorPlace
Safeguard Your Future: Top 3 Stocks to Weather Any Market Downturn
Explore three stocks that will resist a market downturn that offer both stability and potential growth during economic fluctuations. 
Via InvestorPlace
3 Profitable Dividend Stocks to Buy at Near-Lows
With high yields above 3% and dirt-cheap valuations, these undervalued dividend stocks present a significant margin of safety. 
Via InvestorPlace
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
The second wave of the weight loss drug stock boom is underway and investors should heed the signs the market is serving. 
Via InvestorPlace
2 No-Brainer Dividend Stocks to Buy in May
These two blue chip dividend stocks are top buys right now. 
Via The Motley Fool
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists. 
Via Benzinga
This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream
Pfizer's new product lineup could allow the pharmaceutical giant to push its dividend steadily higher for another 15 years. 
Via The Motley Fool
Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac
Pfizer settles 10,000 Zantac lawsuits over cancer risks, but challenges remain. Details undisclosed. Sanofi's $100 million+ agreement also noted. Legal battles ongoing. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Second Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle Wasting Disorder Trial
A young patient passed away from cardiac arrest after receiving Pfizer's experimental gene therapy for Duchenne muscular dystrophy. Pfizer investigates while trials continue, including Phase 3 study.... 
Via Benzinga
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.